ROBERTS EIRY — SEC Form 4 filings
SEC reporting owner CIK 1727606. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-02 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 6 filings — 9,327 shares, $1,240,974 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 1,457 shares @ $152.80 ($222,636) in NEUROCRINE BIOSCIENCES INC, filed 2025-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Medical Officer | 8 | — | 9 legs · 9,327 sh · $1,240,974 | 24 |
| AMICUS THERAPEUTICS, INC. (FOLD) | Director | 3 | — | — | 10 |
| Bausch Health Companies Inc. (BHC) | Director | 1 | — | — | 1 |
Form 4 filings — ROBERTS EIRY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4 | Bausch Health Companies Inc. (BHC) | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-04-27 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to issuer (D): 76,275 @ $14.50 · Disposition to issuer (D): 40,625 (derivative) · Disposition to issuer (D): 45,423 (derivative) · Disposition to issuer (D): 30,474 (derivative) · Disposition to issuer (D): 42,467 (derivative) · Disposition to issuer (D): 74,872 (derivative) | EDGAR |
| 2025-06-06 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 20,414 @ $0 · Grant/award (A): 74,872 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,113 @ $0 · Sale (S): 1,114 @ $116.90 · Option exercise (M): 1,120 @ $0 · Sale (S): 604 @ $116.74 · Option exercise (M): 1,372 @ $0 · Sale (S): 500 @ $115.04 · +5 more | EDGAR |
| 2025-02-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,860 @ $0 · Sale (S): 980 @ $118.22 · Option exercise (M): 1,860 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,769 @ $0 · Sale (S): 1,457 @ $152.80 · Option exercise (M): 2,769 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 5,487 (derivative) @ $0 · Grant/award (A): 27,770 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 5,140 @ $77.81 · Option exercise (M): 1,233 @ $81.05 · Option exercise (M): 971 @ $102.90 · Option exercise (M): 1 @ $79.02 · Option exercise (M): 5,140 (derivative) @ $0 · Option exercise (M): 1,233 (derivative) @ $0 · +2 more | EDGAR |
| 2024-06-07 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 11,847 @ $0 · Grant/award (A): 42,467 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,114 @ $132.96 · Grant/award (A): 22,529 (derivative) @ $0 · Grant/award (A): 4,483 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,121 @ $142.24 · Sale (S): 980 @ $134.21 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,457 @ $140.79 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1727606 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →